MoneyWorks4Me

Caplin Point Laboratories informs about press release

01 Jan 2026 Evaluate

Caplin Point Laboratories has informed that it enclosed a Press Release regarding acquisition of ten approved Abbreviated New Drug Applications (ANDAs) for Injectable and Opthalmic products from a leading Multinational Generic product manufacturing company.

The above information is a part of company’s filings submitted to BSE.


Peers
Company Name CMP
Sun Pharma. Inds. 1865.00
Dr. Reddys Labs. 1210.10
Cipla 1380.00
Lupin 2100.00
Zydus Lifesciences 1169.50
View more..